Sentences with phrase «receiving standard chemotherapies»

While trilaciclib has a huge potential market among cancer patients receiving standard chemotherapies, investors want to keep their eyes on an ongoing trial evaluating a triple - combination of Roche's (NASDAQOTH: RHHBY) Tecentriq, chemotherapy, and G1's candidate.

In a study presented today at a meeting of women's cancer specialists, overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy treatment alone.

Those who received standard chemotherapy plus Avastin, and then maintenance Avastin, for up to 10 months lived just over 14 months without their disease progressing compared with about 10 months for those receiving standard chemotherapy alone.

That means they have a high likelihood of disease recurrence and poor survival odds despite receiving standard chemotherapy and optimum surgery.

Not exact matches

Now, patients with PD - L1 expression on at least half of their cancer cells can receive pembrolizumab prior to standard chemotherapy.

In a head - to - head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found that people with squamous - non-small cell lung cancer who received nivolumab lived, on average, 3.2 months longer than those receiving chemotherapy.

Additionally, due to other medical issues or poor performance status (a measure that considers a patient's quality of life and ability to function during treatment), some stage III NSCLC patients are unable to receive the standard treatment of concurrent chemotherapy and RT..

Patients were randomized to receive either nivolumab or a single type of standard chemotherapy until tumor progression was observed.

A third group of mice received the standard high dose of chemotherapy at first, but once the animals» tumours started to shrink, the researchers dialled back the dose.

A large trial showing that men with newly diagnosed, advanced prostate cancer lived ten months longer, on average, when they received docetaxel chemotherapy along with standard hormone therapy

One hundred and one patients with metastatic uveal melanoma at 15 centers in the United States and Canada were randomized to receive either selumetinib or standard chemotherapy.

Dr Fiona Blackhall, a senior lecturer in The University of Manchester's Institute of Cancer Sciences and a consultant based at The Christie NHS Foundation Trust — both part of the Manchester Cancer Research Centre — said: «In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.»

It showed that those patients who received crizotinib did better with respect to improvement in symptoms and delay in growth of the cancer than those on standard chemotherapy.

For a median (midpoint) PFS of 6.4 months in patients treated with standard chemotherapy, the corresponding reduction of PFS in patient receiving EGFR TKI would be 1.9 months.

Patients were randomized to receive either immunotherapy or standard - of - care chemotherapy.

Two patients that had previously not responded to available standard treatments, including surgery, external radiation, hormonal and chemotherapy, have received 225Actinium - PSMA - 617 as experimental therapy.

In phase 3 trials for adults with high - risk, secondary AML, there was a statistically significant improvement in overall survival compared to patients who received a regimen using chemotherapy drugs delivered in the standard way.

The 11 evaluable patients enrolled in the brain cancer safety trial received three infusions of vitamin C a week for 2 months followed by two infusions per week for 7 months while receiving standard care radiation and chemotherapy.

(In clinical trials, HER2 - positive patients receiving Herceptin and standard combination chemotherapy had a 52 percent decrease in disease recurrence compared with patients treated with chemotherapy alone.)

Standard chemotherapy is toxic to both cancer cells and normal cells, leading to symptoms like nausea, and limiting the dose a person can receive.

Each patient will receive gemcitabine and nab - paclitaxel, two chemotherapy drugs that are standard of care.

«In the study, investigators randomized 40 newly diagnose NSCLC patients to receive either fish oil (EPA 2.2 g / day) or standard care (no intervention; n = 24) while undergoing first - line chemotherapy for 10 weeks.The investigator found that about 69 % of the patients who took fish oil gained or maintained muscle mass.

When results of treatment with standard chemotherapy alone versus chemotherapy plus Herceptin were compared, it was found that tumors shrank at least 50 percent in half the women getting chemotherapy with Herceptin, compared with one - third of women receiving chemotherapy alone.

Ten dogs with multicentric lymphoma will be recruited to receive HBRT in conjunction with standard chemotherapy.

Dogs with previously untreated, stage III to V, non-small cell lymphoma receiving the standard (16 - treatment) UW - Madison CHOP chemotherapy protocol will qualify for treatment with radiation.

The case involved a 43 year old breast cancer patient who was receiving chemotherapy at dose administered 80 % higher than the standard.